These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1868 related articles for article (PubMed ID: 28373086)
1. Optical imaging and anticancer chemotherapy through carbon dot created hollow mesoporous silica nanoparticles. Kang MS; Singh RK; Kim TH; Kim JH; Patel KD; Kim HW Acta Biomater; 2017 Jun; 55():466-480. PubMed ID: 28373086 [TBL] [Abstract][Full Text] [Related]
2. Hybrid silica-coated Gd-Zn-Cu-In-S/ZnS bimodal quantum dots as an epithelial cell adhesion molecule targeted drug delivery and imaging system. Akbarzadeh M; Babaei M; Abnous K; Taghdisi SM; Peivandi MT; Ramezani M; Alibolandi M Int J Pharm; 2019 Oct; 570():118645. PubMed ID: 31465835 [TBL] [Abstract][Full Text] [Related]
3. Luminescent mesoporous nanoreservoirs for the effective loading and intracellular delivery of therapeutic drugs. Kwon S; Singh RK; Kim TH; Patel KD; Kim JJ; Chrzanowski W; Kim HW Acta Biomater; 2014 Mar; 10(3):1431-42. PubMed ID: 24239681 [TBL] [Abstract][Full Text] [Related]
4. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin. Gupta B; Poudel BK; Ruttala HB; Regmi S; Pathak S; Gautam M; Jin SG; Jeong JH; Choi HG; Ku SK; Yong CS; Kim JO Acta Biomater; 2018 Oct; 80():364-377. PubMed ID: 30201431 [TBL] [Abstract][Full Text] [Related]
5. pH-responsive unimolecular micelle-gold nanoparticles-drug nanohybrid system for cancer theranostics. Lin W; Yao N; Qian L; Zhang X; Chen Q; Wang J; Zhang L Acta Biomater; 2017 Aug; 58():455-465. PubMed ID: 28583900 [TBL] [Abstract][Full Text] [Related]
6. Fluorescent carbon dot-gated multifunctional mesoporous silica nanocarriers for redox/enzyme dual-responsive targeted and controlled drug delivery and real-time bioimaging. Wang Y; Cui Y; Zhao Y; He B; Shi X; Di D; Zhang Q; Wang S Eur J Pharm Biopharm; 2017 Aug; 117():105-115. PubMed ID: 28363599 [TBL] [Abstract][Full Text] [Related]
7. Merging metal organic framework with hollow organosilica nanoparticles as a versatile nanoplatform for cancer theranostics. Chen L; Zhang J; Zhou X; Yang S; Zhang Q; Wang W; You Z; Peng C; He C Acta Biomater; 2019 Mar; 86():406-415. PubMed ID: 30625415 [TBL] [Abstract][Full Text] [Related]
8. An RGD-modified hollow silica@Au core/shell nanoplatform for tumor combination therapy. Li X; Xing L; Hu Y; Xiong Z; Wang R; Xu X; Du L; Shen M; Shi X Acta Biomater; 2017 Oct; 62():273-283. PubMed ID: 28823719 [TBL] [Abstract][Full Text] [Related]
9. Graphene quantum dots-gated hollow mesoporous carbon nanoplatform for targeting drug delivery and synergistic chemo-photothermal therapy. Fang J; Liu Y; Chen Y; Ouyang D; Yang G; Yu T Int J Nanomedicine; 2018; 13():5991-6007. PubMed ID: 30323587 [TBL] [Abstract][Full Text] [Related]
10. Aerosol technique-based carbon-encapsulated hollow mesoporous silica nanoparticles for synergistic chemo-photothermal therapy. Gautam M; Thapa RK; Poudel BK; Gupta B; Ruttala HB; Nguyen HT; Soe ZC; Ou W; Poudel K; Choi HG; Ku SK; Yong CS; Kim JO Acta Biomater; 2019 Apr; 88():448-461. PubMed ID: 30818051 [TBL] [Abstract][Full Text] [Related]
11. Triple stimuli-responsive ZnO quantum dots-conjugated hollow mesoporous carbon nanoplatform for NIR-induced dual model antitumor therapy. Feng S; Mao Y; Wang X; Zhou M; Lu H; Zhao Q; Wang S J Colloid Interface Sci; 2020 Feb; 559():51-64. PubMed ID: 31610305 [TBL] [Abstract][Full Text] [Related]
12. Preparation of Self-Activated Fluorescence Mesoporous Silica Hollow Nanoellipsoids for Theranostics. Singh RK; Kim TH; Mahapatra C; Patel KD; Kim HW Langmuir; 2015 Oct; 31(41):11344-52. PubMed ID: 26393922 [TBL] [Abstract][Full Text] [Related]
13. Zwitterionic mesoporous nanoparticles with a bioresponsive gatekeeper for cancer therapy. Khatoon S; Han HS; Lee M; Lee H; Jung DW; Thambi T; Ikram M; Kang YM; Yi GR; Park JH Acta Biomater; 2016 Aug; 40():282-292. PubMed ID: 27063494 [TBL] [Abstract][Full Text] [Related]
14. Redox-responsive mesoporous selenium delivery of doxorubicin targets MCF-7 cells and synergistically enhances its anti-tumor activity. Zhao S; Yu Q; Pan J; Zhou Y; Cao C; Ouyang JM; Liu J Acta Biomater; 2017 May; 54():294-306. PubMed ID: 28267598 [TBL] [Abstract][Full Text] [Related]
15. Copper sulfide nanoparticle-based localized drug delivery system as an effective cancer synergistic treatment and theranostic platform. Hou L; Shan X; Hao L; Feng Q; Zhang Z Acta Biomater; 2017 May; 54():307-320. PubMed ID: 28274767 [TBL] [Abstract][Full Text] [Related]
16. Cancer cell membrane-cloaked mesoporous silica nanoparticles with a pH-sensitive gatekeeper for cancer treatment. Liu CM; Chen GB; Chen HH; Zhang JB; Li HZ; Sheng MX; Weng WB; Guo SM Colloids Surf B Biointerfaces; 2019 Mar; 175():477-486. PubMed ID: 30572156 [TBL] [Abstract][Full Text] [Related]
17. N-Doped graphene quantum dot@mesoporous silica nanoparticles modified with hyaluronic acid for fluorescent imaging of tumor cells and drug delivery. Gui W; Zhang J; Chen X; Yu D; Ma Q Mikrochim Acta; 2017 Dec; 185(1):66. PubMed ID: 29594582 [TBL] [Abstract][Full Text] [Related]
18. Tumor-targeted and multi-stimuli responsive drug delivery system for near-infrared light induced chemo-phototherapy and photoacoustic tomography. Feng Q; Zhang Y; Zhang W; Shan X; Yuan Y; Zhang H; Hou L; Zhang Z Acta Biomater; 2016 Jul; 38():129-42. PubMed ID: 27090593 [TBL] [Abstract][Full Text] [Related]
19. Hollow Mesoporous Silica Nanoparticles Gated by Chitosan-Copper Sulfide Composites as Theranostic Agents for the Treatment of Breast Cancer. Niu S; Zhang X; Williams GR; Wu J; Gao F; Fu Z; Chen X; Lu S; Zhu LM Acta Biomater; 2021 May; 126():408-420. PubMed ID: 33731303 [TBL] [Abstract][Full Text] [Related]
20. Luminescent carbon dot-gated nanovehicles for pH-triggered intracellular controlled release and imaging. Zhou L; Li Z; Liu Z; Ren J; Qu X Langmuir; 2013 May; 29(21):6396-403. PubMed ID: 23642102 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]